Concord Drugs fundamental analysis
CONCORD
81.3
0.57 (-0.70%)Last updated on 20 Jan, 2026 | 10:42 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Concord Drugs Fundamentals
P/E Ratio
182.99
P/B Ratio
2.29
Div. Yield
0
Sector P/E
69.39
Sector P/B
0.98
Sec. Div. Yield
0.57
Concord Drugs Fundamentals is currently trading with a P/E Ratio of 182.99, compared to the sector average of 69.39. Its P/B Ratio stands at 2.29, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Concord Drugs Score Card
Price
Expensive
Growth
Good
Quality
Poor
Management
Poor
On its scorecard, Concord Drugs reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
